Veterinary Lab Automation Market Report Scope & Overview:

The Veterinary Lab Automation Market was valued at USD 1.34 Billion in 2025 and is expected to reach USD 3.09 Billion by 2035, growing at a CAGR of 8.71% from 2026–2035.

Pet owners today expect the same speed and precision from their vet's lab work that they'd expect from their own doctor's office, and that expectation has genuinely reshaped how veterinary clinics operate. Rising companion animal ownership, growing awareness of preventive animal healthcare, and expanding livestock populations have all pushed clinics and diagnostic centers toward automated systems that can process samples faster and more consistently than manual testing ever could. Zoonotic disease surveillance adds another layer of urgency here, since catching a pathogen early in an animal population can prevent it from spreading further, and automated molecular diagnostics have become an increasingly important tool for exactly that kind of early detection.

In 2025, about 94 million U.S. households own at least one pet, representing 71% of all households, with roughly 68 million owning dogs and 49 million owning cats. Globally, there are approximately 900 million pet dogs and 370 million pet cats as of 2024–2025, a genuinely enormous population of companion animals that all require some level of veterinary care.

Market Size and Forecast

  • Market Size in 2026E: USD 1.46 Billion

  • Market Size by 2035: USD 3.09 Billion

  • CAGR: 8.71% from 2026 to 2035

  • Fastest Growing Region: Asia Pacific

  • Largest Region: North America

Veterinary Lab Automation Market Trends

  • Automated diagnostic analyzers are seeing rising adoption as clinics look for faster, more accurate testing across routine and complex cases alike.

  • AI and machine learning are increasingly built into veterinary diagnostic workflows, supporting everything from cytology interpretation to hematology analysis.

  • High-throughput systems are gaining traction in large veterinary hospitals and labs handling growing caseloads.

  • Molecular diagnostic automation continues expanding, driven largely by zoonotic disease surveillance needs.

  • Cloud-based software for real-time lab data tracking and reporting is becoming a more standard part of how veterinary labs manage their workflows.

The U.S. Veterinary Lab Automation Market Outlook

The U.S. Veterinary Lab Automation Market was valued at approximately USD 0.38 Billion in 2025 and is expected to reach approximately USD 0.87 Billion by 2035, growing at a CAGR of approximately 8.69%.

Growth in the U.S. market is still being fueled by increased pet ownership, more investment in pet health care services and the need for rapid diagnosis. An increase in veterinary clinics along with constant technological development makes adoption of automation technologies inevitable.

During May 2025, IDEXX Laboratories published its earnings for the first quarter and revealed the installation of more than 300 units of inVue Dx slide-free cellular analyzer throughout the globe, reflecting high adoption of point-of-care devices from IDEXX and increased automation in laboratory workflow. This indicates real-time market demand and not just another product introduction.

Veterinary Lab Automation Market Segment Analysis

  • By Product Type, analytical systems led the market with a 52% share in 2025, while software is the fastest-growing segment through 2035.

  • By Application, immunodiagnostics led the market with a 29% share in 2025, while molecular diagnostics is the fastest-growing segment through 2035.

  • By End-User, veterinary hospitals led the market with a 43% share in 2025, and is also expected to grow the fastest through 2035.

By Product Type, analytical systems dominate, software grows fastest

Analytical instruments were the key players in 2025 due to the significant role they played in tests that needed to be performed frequently, the high level of accuracy, and their popularity in different diagnostic tests like hematology and clinical chemistry. Due to their efficiency, reliability, and fast operation, they remain almost essential for veterinarians.

The software market is expected to record the highest CAGR through 2035 as more laboratories use digital systems to integrate data, automate work processes, monitor remotely, and report in real time. The increasing need for cloud solutions, enhanced connectivity with instrumentation, and improved decision-making tools has further driven software usage.

By Application, immunodiagnostics dominates, molecular diagnostics grows fastest

In 2025, the immunodiagnostics segment accounted for a significant share in the market due to the vast usage of this technique in the diagnosis of infectious diseases, hormonal assays, and regular testing. Increased sensitivity, shorter time frames, and detection of various biomarkers keep immunodiagnostics relevant in the diagnostics process.

The molecular diagnostics market is expected to exhibit the highest CAGR till 2035 owing to the increasing demand for accurate identification of pathogens, an increasing emphasis on the monitoring of zoonotic diseases, and increased application of PCR technology and DNA & RNA testing. The development in automation technology along with reduced cost is propelling its adoption.

By End-User, veterinary hospitals dominate and continue expanding fastest

Veterinary hospitals led the market in 2025, driven by increasing caseloads, rising pet ownership, and genuine need for rapid, on-site diagnostic results. Their growing adoption of automated analyzers, integrated software, and advanced testing capability continues supporting faster decision-making and better patient outcomes.

Veterinary hospitals are also projected to be the fastest growing CAGR for 2035 as the need for increased efficiency continues to grow with increased case numbers. Clinics that have adopted automation have seen improved efficiency and reliability of diagnostics, solidifying hospitals as the largest and fastest growing end user category.

Regional Analysis

Region

Major Country

Share within Region, 2025 (%)

North America

United States

80.0%

Europe

Germany

25.0%

Asia Pacific

China

38.0%

Latin America

Brazil

36.0%

Middle East & Africa

UAE

26.0%

North America Veterinary Lab Automation Market Insights

North America had a dominant market share of 38% in 2025 due to its sophisticated veterinary healthcare infrastructure, greater adoption of automation in diagnostics, and the presence of major industry players. The growing number of pets and investments in animal health along with modern laboratories have continued to drive the regional dominance in veterinary diagnostics.

North America is dominated by the United States in the automated veterinary lab testing space, especially due to the high level of development of veterinary facilities, automation use, and high research investments in this area, along with growing demand for companion animal diagnostics.

Europe Veterinary Lab Automation Market Insights

Europe holds a significant share of the market, owing to well-established veterinary healthcare systems, strong regulatory focus on animal health, and widespread adoption of advanced diagnostic technology. The region benefits from high awareness of preventive veterinary care and rising demand for automated testing across both companion animal and livestock sectors.

A strong presence of research institutes and diagnostic laboratories continues driving ongoing technological advancement across the region, positioning Europe as a technically sophisticated, if more measured, growth market relative to Asia Pacific and North America.

Asia Pacific Veterinary Lab Automation Market Insights

Asia Pacific is projected to grow at the fastest CAGR, at around 11.04% from 2026 to 2035, driven by rapid expansion of veterinary clinics, rising awareness of animal health, and increasing investment in diagnostic infrastructure. Growing livestock populations, rising companion animal adoption, and government initiatives supporting veterinary disease surveillance continue encouraging automated laboratory system adoption across developing economies in the region.

China leads the Asia Pacific veterinary lab automation market, supported by strong biotech investment, rapid AI-enabled automation uptake, and expanding diagnostic and research capacity. That combination of policy support and biotech investment positions Asia Pacific to keep outpacing every other region in growth rate through the forecast period.

MEA & Latin America Veterinary Lab Automation Market Insights

The Middle East and Africa and Latin America are seeing steady growth in veterinary lab automation as investments in animal healthcare, diagnostics, and disease surveillance continue increasing. Rising livestock populations and growing zoonotic disease concerns continue driving adoption of automated analyzers and digital solutions across both regions.

Expanding veterinary services, particularly in Brazil, Mexico, and major MEA markets, continue driving laboratories to modernize their workflows and invest in automated systems as regional healthcare infrastructure keeps maturing.

Market Dynamics

Growth Drivers: Rising companion animal ownership sustains demand for advanced diagnostics

The rising trend of adopting pets worldwide is leading to an ever-growing need for accurate diagnosis testing services, compelling veterinarians’ clinics, hospitals, and laboratories to equip themselves with automated diagnostic devices. With more awareness about preventive health care among pet owners and their growing demands for quality services, there is a need for efficient testing services among veterinarians.

Automated analyzers and integrated lab systems help meet this rising diagnostic workload by improving efficiency, reducing manual errors, and enabling quicker decision-making, ultimately supporting better clinical outcomes for companion animals. The rapid increase in veterinary clinics, animal hospitals, and specialized diagnostic laboratories adds further momentum, as expanding caseloads push facilities toward faster, more consistent, high-volume diagnostic capability.

Restraints: High upfront investment costs limit adoption among smaller clinics

Automated veterinary laboratory systems such as automated analyzers, fully integrated system laboratories, and highly advanced diagnostic technologies need heavy initial investments. In the case of small and medium-sized veterinary clinics and diagnostic facilities especially in developing nations, the cost involved could be highly prohibitive, and other costs associated with installation and training would make matters worse.

Initial setup costs for automation equipment, IT systems, and staff training can consume 15 to 20% of total project expenses, discouraging smaller or budget-limited practices from adopting advanced diagnostic automation. Automated lab systems costing USD 50,000 to USD 150,000, plus ongoing maintenance, software, and training expenses, make adoption a genuinely difficult decision for facilities without unclear short-term ROI justification.

Opportunities: Growing research investment and point-of-care demand create meaningful upside

The increase in the investment in the areas of veterinary research, biotech, and academics is increasing the requirement for advanced lab automation systems. With the increased capacity to perform molecular diagnostics, genomics, infection research, and vaccines at the veterinary universities and research institutions, there will be a need for standard, reliable, and automated test systems.

The additional requirement for POC and rapid test systems creates an additional area of opportunity as the veterinarians are looking for portable and easy-to-use automated test systems that provide real-time results for better decision-making. With the continued focus on making a timely diagnosis by the pet owners and livestock owners, there will be a rising requirement for POC devices.

Recent Developments:

  • 2024: In January 2024, IDEXX Laboratories launched the inVue Dx slide-free cellular analyzer, enabling automated cytology and blood-morphology evaluation to streamline in-clinic diagnostic workflows.

  • 2024: In September 2024, Zoetis announced a new cartridge-based AI-powered hematology analyzer, enhancing automation and precision in in-clinic blood analysis.

  • 2025: In June 2025, Zoetis launched AI Masses, an AI-powered cytology feature for its Vet Scan Imagyst analyzer, improving automated detection and interpretation of cytologic samples.

Veterinary Lab Automation Market key players are:

  • IDEXX Laboratories, Inc.

  • Zoetis Inc.

  • Heska Corporation

  • Sysmex Corporation

  • HORIBA Ltd.

  • Boule Medical AB

  • HemoCue AB

  • Shenzhen Mindray Animal Medical Technology Co., Ltd.

  • Antech Diagnostics, Inc.

  • Scopio Labs

  • Thermo Fisher Scientific Inc.

  • bioMérieux SA

  • Randox Laboratories Ltd.

  • Siemens Healthineers AG

  • Covetrus Inc.

  • PetDx

  • FUJIFILM Healthcare Corporation

  • QIAGEN N.V.

  • Roche Diagnostics

  • Abaxis, Inc.

Veterinary Lab Automation Market Report Scope:

Report Attributes Details
Market Size in 2025 USD 1.34 Billion 
Market Size by 2035 USD 3.09 Billion 
CAGR CAGR of 8.71% From 2026 to 2035
Base Year 2025
Forecast Period 2026-2035
Historical Data 2022-2024
Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product Type (Pre-Analytical Systems, Analytical Systems, Post-Analytical Systems, Software, Others)
• By Application (Clinical Chemistry, Hematology, Immunodiagnostics, Molecular Diagnostics, Others)
• By End-User (Veterinary Hospitals, Diagnostic Laboratories, Research Institutes, Others)
Regional Analysis/Coverage North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).
Company Profiles IDEXX Laboratories, Inc., Zoetis Inc., Heska Corporation, Sysmex Corporation, HORIBA Ltd., Boule Medical AB, HemoCue AB, Shenzhen Mindray Animal Medical Technology Co., Ltd., Antech Diagnostics, Inc., Scopio Labs, Thermo Fisher Scientific Inc., bioMérieux SA, Randox Laboratories Ltd., Siemens Healthineers AG, Covetrus Inc., PetDx, FUJIFILM Healthcare Corporation, QIAGEN N.V., Roche Diagnostics, Abaxis, Inc.